Search company, investor...

Predict your next investment

GreenSky Ventures company logo
Venture Capital
greensky.vc

Investments

35

Portfolio Exits

2

Funds

6

About GreenSky Ventures

GreenSky Ventures manages a series of venture capital funds that invest in early-stage, B2B-focused Canadian start-ups. It looks for long-term partnerships with high-growth potential companies and dedicated entrepreneurs and focuses on companies with complex intellectual property-seeking support scaling their businesses. It was founded in 2010 and is based in Toronto, Canada.

Headquarters Location

6 Adelaide Street East Suite 500

Toronto, Ontario, M5J 1T1,

Canada

416-585-7850

Are you an investor?
Submit your portfolio details now to be considered in our investor rankings.

Latest GreenSky Ventures News

Wisedocs secures US $9.5M Series A

Jan 31, 2024

Wisedocs secures US $9.5M Series A CPE News (1.31.2024) – Wisedocs Inc. has raised US $9.5 million in oversubscribed Series A financing led by Information Venture Partners, with participation of Thomson Reuters Ventures and ManchesterStory. Wisedocs’ investors also include Ripple Ventures which led Wisedocs’ CDN $4.1 million seed financing with participation from Greensky Capital, George A. Papayiannis and Tim Lett in March 2022. Founded by CEO Connor Atchison and COO Jenna Earnshaw in Geulph, Ontario, Toronto based Wisedocs is a provider of machine learning software-as-a-service (SaaS) for medical record review, indexing, and summarization. photo credit: Wisedocs News Release Wisedocs, Technology Market Leader for the Insurance Industry, Closes $12.7M Oversubscribed Series A as It More Than Doubles Customer Base January 30, 2024 09:00 AM Eastern Standard Time TORONTO–(BUSINESS WIRE)–Wisedocs, machine learning software-as-a-service (SaaS) for medical record review, indexing, and summarization closes $9.5M USD ($12.7M CAD) in oversubscribed Series A financing. The Series A is led by Information Venture Partners, an early-stage B2B fintech investment firm; and by Thomson Reuters Ventures and ManchesterStory. Connor Atchison, Founder and CEO of Wisedocs, states, “This latest financing round proves the success of our most recent technological advancements. The claims ecosystem has long remained a siloed and slow-moving machine. With the improvements in automation, intelligence, and centralization that Wisedocs enables, the claims process will be an efficient experience for companies, team members, and claimants alike.” This financing round follows Wisedocs’ successful 2022 $4.1M oversubscribed Seed round. The Series A further enables Wisedocs’ successful expansion of its team, product, and sales territories. Wisedocs launched in the United States in 2022, followed by the opening of new American headquarters in Florida to support a growing US customer base. Wisedocs is poised to accelerate exponentially in 2024 following a successful 2023, which saw the company more than double its growth in customer base, alongside an incredible 3.5X growth rate. “We are proud to lead Wisedocs’ Series A round,” notes Jane Podbelskaya of Information Venture Partners, investor, and newest board member at Wisedocs. “The unique way in which the company is applying AI to analyze medical claims, an overwhelming demand for Wisedocs’ solution from various insurance industry players, and the CEO’s noble mission to improve lives of insurance claimants is what makes us particularly excited about this company. This round enables its continued growth and expansion.” Leveraging state-of-the-art Generative Artificial Intelligence (AI) to build its latest product suite enables the entire claims ecosystem to manage the claims process within an intelligent technology platform. Large-Language Models (LLMs) are key to Wisedocs’ understanding, analysis, and generation of content for medical records. With the 2023 launch of its game-changing Summaries platform, further artificial intelligence products can be launched to support insurance carriers, healthcare providers, law firms, and third-party administrators (TPAs) for the claims industry. “Wisedocs has developed a game changing solution that applies generative AI to insurance claims processing and summarization,” stated Tamara Steffens, Managing Director, Thomson Reuters Ventures. “We are excited to work with them to bring this solution to our legal customers.” The insurance industry has long suffered from manual, slow processes that impact claimants and the claims ecosystem – from the insurance companies involved to the legal teams and medical practices. “The insurance industry knows the plight of their practice and workers, as well as their claimants as it pertains to processing claims effectively, efficiently, and accurately,” begins Matt Kinley, Founding Partner at ManchesterStory. “It is no surprise that Wisedocs has successfully integrated its AI technology into the claims ecosystem at such a fast adoption rate. Its technology is a welcome change to how claims are processed.” From exponential customer engagement, Wisedocs grew to support all facets of the claims process by creating a platform that allows for AI timeline view, search, filter, summarization, and more on extensive medical records. This allows claims to be processed faster and more accurately within a secure platform. About Wisedocs Wisedocs is the medical record indexing, review, and AI summaries software platform for insurance carriers, healthcare providers, law firms, and TPAs for the claims industry. Wisedocs serves the auto, liability, disability, workers’ compensation, tort law, and similar markets. Wisedocs provides an easy-to-integrate solution for improved accuracy and speed to deliver improved outcomes in processing medical records. Wisedocs raised $4.1M in an oversubscribed seed round in 2022 and launched their game-changing Summaries platform in 2023. Launched in 2021, and expanded across North America, Wisedocs is at the forefront of change in the claims ecosystem. About Information Venture Partners Information Venture Partners is a Toronto-based team of experienced venture capital investors focused on backing the next generation of leaders in B2B FinTech and Enterprise SaaS for Financial Institutions. Current investments include Arteria AI, BigID, Cinchy, Coconut Software, Empyrean Solutions, Flybits, FX HedgePool, Helcim, Influitive, Jirav, Knowtions, LendingFront, Lydia AI, Nue.io, Procurify, Q4, Strike Graph, ThoughtExchange and Wisedocs. For more information, please visit www.informationvp.com. About ManchesterStory Founded by Dave Miles and Matt Kinley, ManchesterStory Group is a venture capital firm targeting investments in FinTech and Healthcare, with a particular interest in technologies impacting the insurance industry. Focused on early to growth-stage companies across the United States, ManchesterStory seeks to generate superior returns by connecting exceptional entrepreneurs to strategic capital and relationships. Contacts

GreenSky Ventures Investments

35 Investments

GreenSky Ventures has made 35 investments. Their latest investment was in Brickeye as part of their Series B on October 31, 2023.

CBI Logo

GreenSky Ventures Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

10/31/2023

Series B

Brickeye

$10M

No

1

9/25/2023

Seed VC

Captain AI

$1.98M

Yes

1

9/7/2023

Seed VC

Mission Control

$1.75M

Yes

Undisclosed Angel Investors

2

6/15/2023

Series A

Subscribe to see more

$99M

Subscribe to see more

10

12/23/2022

Series C - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

10/31/2023

9/25/2023

9/7/2023

6/15/2023

12/23/2022

Round

Series B

Seed VC

Seed VC

Series A

Series C - II

Company

Brickeye

Captain AI

Mission Control

Subscribe to see more

Subscribe to see more

Amount

$10M

$1.98M

$1.75M

$99M

$99M

New?

No

Yes

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Undisclosed Angel Investors

Sources

1

1

2

10

10

GreenSky Ventures Portfolio Exits

2 Portfolio Exits

GreenSky Ventures has 2 portfolio exits. Their latest portfolio exit was Cyclica on May 08, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/8/2023

Acquired

$99M

2

9/8/2020

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

5/8/2023

9/8/2020

Exit

Acquired

Acquired

Companies

Subscribe to see more

Valuation

$99M

$99M

Acquirer

Subscribe to see more

Sources

2

10

GreenSky Ventures Fund History

6 Fund Histories

GreenSky Ventures has 6 funds, including GreenSky Accelerator Fund V.

Closing Date

Fund

Fund Type

Status

Amount

Sources

2/13/2023

GreenSky Accelerator Fund V

$12.74M

1

6/4/2021

GreenSky Accelerator Fund IV

$99M

10

1/20/2020

GreenSky Accelerator Fund III, LP

$99M

10

7/26/2017

GreenSky Accelerator Fund II

$99M

10

7/8/2015

GreenSky Accelerator Fund I

$99M

10

Closing Date

2/13/2023

6/4/2021

1/20/2020

7/26/2017

7/8/2015

Fund

GreenSky Accelerator Fund V

GreenSky Accelerator Fund IV

GreenSky Accelerator Fund III, LP

GreenSky Accelerator Fund II

GreenSky Accelerator Fund I

Fund Type

Status

Amount

$12.74M

$99M

$99M

$99M

$99M

Sources

1

10

10

10

10

GreenSky Ventures Team

4 Team Members

GreenSky Ventures has 4 team members, including , .

Name

Work History

Title

Status

Geoff Simonett

Founder

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Geoff Simonett

Subscribe to see more

Subscribe to see more

Subscribe to see more

Work History

Title

Founder

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Loading...

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.